LONDON, April 9, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Biosensors in US$ Million by the following Product Segments: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 72 companies including many key and niche players such as -
Abbott Point Of Care, Inc.
Animas Corporation
Bio-Rad Laboratories, Inc.
GE Healthcare Life Sciences
F. Hoffmann-La Roche Ltd.
Download the full report: https://www.reportbuyer.com/product/2568579/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Medical Biosensors I-3
Glucose Biosensors I-4
Other Medical Biosensors I-4
Environmental Biosensors I-4
Other Biosensors I-4
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW II-1
Strong Growth on Cards for Biosensors II-1
A Glance at Key Trends & Developments in Biosensors Market II-2
Recession Leaves Biosensors Market Unruffled II-3
Increasing Medical Applications of Biosensors II-4
Competitive Scenario II-5
Noteworthy Patent Applications for Biosensors in the Years
2013 & 2014 II-6
Competition in the Global Blood Glucose Meters Market II-6
Table 1: Leading Players in the World Blood Glucose Meters
Market (2012): Market Share Breakdown for Roche, LifeScan,
Bayer, Abbott and Others (includes corresponding
Graph/Chart) II-7
2. MARKET DYNAMICS II-8
Alarming Rise in Diabetes: Favorable Prospects for Biosensors
Market II-8
Table 2: Worldwide Prevalence of Diabetes Mellitus by Region
(2013 & 2035) (includes corresponding Graph/Chart) II-9
Table 3: Incidence of Diabetes in Select Countries (2013 &
2035) (includes corresponding Graph/Chart) II-10
Table 4: Global Population Statistics for the 65+ Age Group
(2013E) (includes corresponding Graph/Chart) II-11
Increasing Need for Testing: Potential Opportunities for
Biosensors Market II-12
Mobile Glucose Monitoring Devices to Drive Demand for Biosensors II-13
Growth Potential Opportunities in Home & Point of Care Testing
Applications II-14
Rising Demand for Biosensors from POC Testing Applications II-14
Biosensors in Drug Discovery - 'Catching Pace' II-15
Biosensors for Cardiovascular Disease Monitoring II-15
Biosensors in Cholesterol Testing: A Promising Application II-16
Miniature Sensors - The Future of Cholesterol Testing II-16
Biosensors Find Increasing Use in Environmental Applications II-17
Setting New Frontiers for Food Safety Testing - An Emerging
Application II-18
Automotive Sector Offers Sanguine Opportunities II-19
Action against Biological Warfare Agents: Focus on Effective
Biosensors II-19
Growing Focus on Using Nanomaterials in Glucose Biosensors II-20
Nucleic Acid-based Biosensors Find Prominence II-21
Technological Innovations: Spearheading Growth in the
Biosensors Market II-21
Cutting-Edge Design - Order of the Day II-22
Wearable Biosensors - No Longer Science Fiction! II-23
Wearable Sensors for Wound Healing II-24
Biosensors to Check for CO Poisoning Risk II-24
Biosensors to Solve Crime II-24
ESPRIT Program Initiates Biosensors for Sports Applications II-24
Google's Smart Contact Lens for Diabetes Management II-25
Disposable Biosensor Device to Monitor Intestine Rate II-25
Self-Powered Wearable Sensors II-26
Increasing R&D Activity Bodes Well for Biosensors Market II-27
Air Force Research Lab to Conduct Wearable Biosensors Trial
on Marathon Runners II-27
Biosensors in Adhesive Bandages II-28
UCSB Researchers Develop New Biosensor Material II-28
Biosensor Worn on Skin Measures Lactate Levels II-28
Innovative Biosensor Technologies on the Cards II-29
CSIRO Develops Biosensor Platform for Dairy Sector II-29
Researchers Focus on Functionalized Graphene Sheets to
Develop High-Performance Biosensors II-29
Researchers Develop Biosensor Device to Identify Antibiotic-
resistant Bacteria II-30
Organic Thin Film Transistor-based Biosensor to Detect Brain
Injury during Heart Surgeries II-30
Nanotechnology-based Biosensor to Identify Listeria
Monocytogenes in Food Products II-31
EU Scientists Focus on Developing Photonic Biosensors to
Diagnose Food Allergies II-31
ASU Researchers to Develop Biosensor Devices to Identify
Contaminated Drinking Water II-32
Nano-Sized Biosensor Device to Monitor Glucose Levels without
Blood Samples II-32
NYU Researchers Develop Highly Sensitive Biosensor Device to
Detect Small Single Virus Particles II-33
Graphene Biosensor for Tracking Cancer Biomarkers II-33
Oligonucleotide Biosensors - The Road Ahead? II-34
Cell-Based Biosensors on the Rise II-35
Smartphone-based Biosensors to Lead the Future? II-35
smartCARD by Cornell University II-36
iColour Analyser Mobile Application at University of
California, Berkeley II-36
University of Rhode Island II-37
University of Illinois, Urbana-Champaign II-37
Rapid Diagnostic Test Reader of University of California, Los
Angeles II-37
Portable Biosensor Device by OJ-Bio Researchers II-37
Reducing Costs - A Priority for Biosensor Manufacturers II-37
Regulations Encumber Biosensors Market Growth II-38
'Snail'-Paced Commercialization - An Issue to Deal with! II-38
3. PRODUCT OVERVIEW II-40
Biosensors: An Introduction II-40
Historical Perspective II-40
Components of Biosensors II-41
Receptor II-41
Transducer II-41
Separator II-41
Biological Components II-42
Attributes of a Good Biosensor II-42
Types of Biosensors II-42
Glucose Sensor II-43
Medical Telesensors II-44
Detecting Cancer and Health Abnormalities II-44
Lactate Sensor II-44
Alcohol Sensor II-44
Biochemical Oxygen Demand Sensor (BOD) II-44
Bioreporters II-44
Miniaturized Devices II-45
Classes of Biosensors II-45
Calorimetric Biosensors II-45
Potentiometric Biosensors II-45
Amperometric Biosensors II-45
Optical Biosensors II-45
Methods to Produce Optical Biosensors II-46
Simple Fiber Optic Biosensors II-46
Evanescent Wave System II-46
Surface Plasmon Resonance (SPR) II-46
Piezoelectric Biosensors II-46
Other Physicochemical Biosensors II-46
4. A GLANCE AT MAJOR APPLICATION AREAS II-47
A. Medical Applications II-47
Glucose Meters II-47
Categorization II-47
Biosensors in Home Glucose Monitors II-47
PBGM Devices: Based on Photometric or Biosensor Technology II-48
Non-Invasive Products II-48
Blood Gas Market II-49
Sensors Facilitate Analysis of Blood II-49
DNA Biosensors and Genechips: A Relatively Nascent Market II-50
B. Environmental Biosensors II-50
C. Industrial Applications II-51
Summarization of Available Biosensors & Technological
Applications II-52
Biological Warfare: An Increasingly Important Area for
Biosensors II-52
Biosensors in Food Industry II-52
Biosensors: Speeding Pathogen Detection II-53
5. PATENT GRANTS/FILINGS/SUBMISSIONS II-54
Eyesense Submits Application for Patent on Using Hydrogels for
Biosensors II-54
Bioglow Seeks Patent for Biosensors II-54
Abbott Bags US Patent for Biosensors II-54
Agency Science Tech & Res Files Patent for Recombinant Protein
Biosensors II-54
Profusa Seeks Patent for Tissue Integrating Sensors II-54
LifeScan Bags Patent for Systems & Devices to Improve
Biosensors Accuracy II-54
Bayer Healthcare Wins Patent on Biosensors II-54
Roche Diagnostics Wins Patent for Biosensor with Predetermined
Dose Response Curve II-55
Microchips Granted Patent on Multi-Channel Potentiostat for
Biosensor Arrays II-55
Delbio Seek Patent for Biosensors II-55
Dow Corning Files Patent to Form Semipermeable Membranes for
Sensor Applications II-55
Protein Technologies Seeks Patent on Biosensors II-55
Lifescan Scotland Files Patent for Using VDAT Nanoparticles in
Biosensors II-55
LG and Researchers Seek Patent for Reagent Composition of
Biosensors II-55
Tyson Bioresearch Bags Patent for Method to Increase Coding
Information for Biosensors II-56
Nova Biomedical Granted Patent for Electrochemical Biosensors II-56
Endotronix Receives Patent for Wireless Reading of Biosensor
Implants II-56
6. PRODUCT LAUNCHES/INNOVATIONS II-57
Propeller Health Receives FDA Approval for Mobile Health
Sensor Devices II-57
dorsaVi Receives FDA Clearance for ViMove Wearable Biosensor II-57
Nano Labs Develops New Miniaturized Tuberculosis Biosensor-
Based Diagnostic Technology II-57
Biosensors International Group Receives CE Mark Approval for
BioFreedom™ II-57
Dexcom Receives FDA Approval for Dexcom G4 Platinum Device II-57
ForteBio Launches Dip and Read Ni-NTA Biosensors II-57
EMD Millipore Unveils LentiBrite Lentiviral Biosensors II-57
Proteus Digital Health Receives FDA Approval for Ingestible
Sensor II-58
PositiveID Corporation Finalizes Development of GlucoChip™ II-58
Meder Unveils MK23 Line of Sensors II-58
Honeywell Unveils NBP Series Pressure Sensors II-58
7. RECENT INDUSTRY ACTIVITY II-59
Intuitive Surgical Acquires Luna's Shape-sensing Technology
for Medical Applications II-59
Citic Group Acquires Stake in Shandong Weigao Group Medical
Polymer II-59
ForteBio Selects MBS MAB230P for Anti-HIS Biosensors II-59
Pharmaco-Kinesis Bags DoD Grant for Biosensor Development II-59
Domain Therapeutics Collaborates with Universities in Canada II-59
Tokyo Electron Collaborates with imec II-59
Sensors for Medicine and Science Undergoes Name Change to
Senseonics II-59
8. FOCUS ON SELECT PLAYERS II-60
Companies Developing Biosensor-Based Devices II-60
Abbott Point Of Care, Inc. (US) II-60
Animas Corporation (US) II-60
Bio-Rad Laboratories, Inc. (US) II-60
GE Healthcare Life Sciences (UK) II-61
F. Hoffmann-La Roche Ltd (Switzerland) II-61
LifeScan, Inc. (US) II-62
Medtronic MiniMed, Inc. (US) II-62
Leading Developers of Biosensor Technology II-63
Abtech Scientific, Inc. (US) II-63
Agamatrix, Inc. (US) II-63
Cambridge Life Sciences Limited (UK) II-63
EMD Millipore Corporation (US) II-63
Innovative Biosensors, Inc. (US) II-64
I-Sens Ltd. (UK) II-64
Nova Biomedical Corp. (US) II-64
PerkinElmer, Inc. (US) II-65
Sigma Aldrich Corporation (US) II-65
9. GLOBAL MARKET PERSPECTIVE II-66
Table 5: World Recent Past, Current & Future Analysis for
Biosensors by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-66
Table 6: World Historic Review for Biosensors by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2012 (includes corresponding Graph/Chart) II-67
Table 7: World 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-68
Global Biosensors Market: Analytics by Product Group/Segment II-69
Table 8: World Recent Past, Current & Future Analysis for
Medical Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-69
Table 9: World Historic Review for Medical Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-70
Table 10: World 15-Year Perspective for Medical Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-71
Table 11: World Recent Past, Current & Future Analysis for
Medical Biosensors by Product Segment - Glucose Biosensors and
Other Medical Biosensors Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-72
Table 12: World Historic Review for Medical Biosensors by
Product Segment - Glucose Biosensors and Other Medical
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-73
Table 13: World 15-Year Perspective for Medical Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Glucose Biosensors and Other Medical Biosensors Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-74
Table 14: World Recent Past, Current & Future Analysis for
Glucose Medical Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-75
Table 15: World Historic Review for Glucose Medical Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-76
Table 16: World 15-Year Perspective for Glucose Medical
Biosensors by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-77
Table 17: World Recent Past, Current & Future Analysis for
Other Medical Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-78
Table 18: World Historic Review for Other Medical Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-79
Table 19: World 15-Year Perspective for Other Medical
Biosensors by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-80
Table 20: World Recent Past, Current & Future Analysis for
Environmental Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-81
Table 21: World Historic Review for Environmental Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-82
Table 22: World 15-Year Perspective for Environmental
Biosensors by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-83
Table 23: World Recent Past, Current & Future Analysis for
Other Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-84
Table 24: World Historic Review for Other Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-85
Table 25: World 15-Year Perspective for Other Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-86
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Outlook III-1
Diabetes Monitoring Market in the US III-1
Table 26: North American Blood Glucose Strips Market
(2012): Percentage Share Breakdown of Dollar Sales of SMBG
Glucose Strips and POC Glucose Strips (includes
corresponding Graph/Chart) III-2
Table 27: North American Diabetes Prevalence Statistics by
Age Group and Gender (2013E) (includes corresponding
Graph/Chart) III-3
Table 28: North America Incidence of Type-1 Diabetes in
Children (2012) (includes corresponding Graph/Chart) III-3
Table 29: Number of Diabetics by Gender in the US (2013E)
(in '000s) (includes corresponding Graph/Chart) III-4
Diabetes in America: Key Facts and Figures III-4
Rising Need for Environmental Monitoring Augurs Well for
Biosensors Market III-5
Product Developments/Approvals/Launches III-6
Strategic Corporate Developments III-7
Key Players III-8
B.Market Analytics III-13
Table 30: US Recent Past, Current & Future Analysis for
Biosensors by Product Group/ Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-13
Table 31: US Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-14
Table 32: US 15-Year Perspective for Biosensors by Product
Group/Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-15
2. CANADA III-16
A.Market Analysis III-16
Outlook III-16
Rising Diabetes Prevalence: A Business Case of Biosensors
Market III-16
Table 33: Adult Diabetes Population by Gender in Canada
(2013) (In '000s) (includes corresponding Graph/Chart) III-16
Table 34: Adult Diabetes Population by Age Group in Canada
(2013) (In '000s) (includes corresponding Graph/Chart) III-17
Biosensor Research in Canada III-17
Strategic Corporate Development III-17
B.Market Analytics III-18
Table 35: Canadian Recent Past, Current & Future Analysis
for Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-18
Table 36: Canadian Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-19
Table 37: Canadian 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-20
3. JAPAN III-21
A.Market Analysis III-21
Overview III-21
Strategic Corporate Development III-21
B.Market Analytics III-22
Table 38: Japanese Recent Past, Current & Future Analysis
for Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-22
Table 39: Japanese Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-23
Table 40: Japanese 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-24
4. EUROPE III-25
A.Market Analysis III-25
Outlook III-25
Rising Prevalence of Diabetes: An Opportunity Indicator III-25
Table 41: European Population and Diabetes Prevalence
Statistics (2013E) - Select Regions with High Prevalence of
Diabetes for Age Groups (20-39, 40-59, and 60-79) and
Gender (includes corresponding Graph/Chart) III-26
Demand for Biosensor Usage in Environmental Monitoring Surges III-26
Safe Drinking Water: Role of Biosensors III-27
Product Approval III-28
B.Market Analytics III-29
Table 42: European Recent Past, Current & Future Analysis
for Biosensors by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-29
Table 43: European Historic Review for Biosensors by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-30
Table 44: European 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-31
Table 45: European Recent Past, Current & Future Analysis
for Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-32
Table 46: European Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-33
Table 47: European 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-34
4a. FRANCE III-35
Market Analysis III-35
Table 48: French Recent Past, Current & Future Analysis for
Biosensors by Product Group/ Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-35
Table 49: French Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-36
Table 50: French 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-37
4b. GERMANY III-38
Market Analysis III-38
Table 51: German Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-38
Table 52: German Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-39
Table 53: German 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-40
4c. ITALY III-41
Market Analysis III-41
Table 54: Italian Recent Past, Current & Future Analysis for
Biosensors by Product Group/ Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-41
Table 55: Italian Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-42
Table 56: Italian 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-43
4d. THE UNITED KINGDOM III-44
A.Market Analysis III-44
Outlook III-44
Diabetes Management - A Key Growth Driver for Biosensors Market III-44
Key Players III-44
B.Market Analytics III-46
Table 57: UK Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-46
Table 58: UK Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-47
Table 59: UK 15-Year Perspective for Biosensors by Product
Group/Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-48
4e. SPAIN III-49
Market Analysis III-49
Table 60: Spanish Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-49
Table 61: Spanish Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-50
Table 62: Spanish 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-51
4f. RUSSIA III-52
Market Analysis III-52
Table 63: Russian Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-52
Table 64: Russian Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-53
Table 65: Russian 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-54
4g. REST OF EUROPE III-55
A.Market Analysis III-55
Outlook III-55
F. Hoffmann-La Roche Ltd. (Switzerland) - A Major Player III-55
B.Market Analytics III-56
Table 66: Rest of Europe Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-56
Table 67: Rest of Europe Historic Review for Biosensors by
Product Group/Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-57
Table 68: Rest of Europe 15-Year Perspective for Biosensors
by Product Group/Segment - Percentage Breakdown of Value
Sales for Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-58
5. ASIA-PACIFIC III-59
A.Market Analysis III-59
Outlook III-59
Rising Diabetes Incidence in Asia-Pacific: An Opportunity
for Biosensors III-59
Table 69: Western Pacific Population and Diabetes
Prevalence Statistics (2013E) - Select Regions with High
Prevalence of Diabetes for Various Age Groups and Gender
(includes corresponding Graph/Chart) III-60
Table 70: South East Asian Population and Diabetes
Prevalence Statistics (2013E) - Select Regions with High
Prevalence of Diabetes for Various Age Groups and Gender
(includes corresponding Graph/Chart) III-61
B.Market Analytics III-62
Table 71: Asia-Pacific Recent Past, Current & Future
Analysis for Biosensors by Geographic Region - China and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-62
Table 72: Asia-Pacific Historic Review for Biosensors by
Geographic Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-63
Table 73: Asia-Pacific 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
China and Rest of Asia-Pacific Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) III-64
Table 74: Asia-Pacific Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-65
Table 75: Asia-Pacific Historic Review for Biosensors by
Product Group/Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-66
Table 76: Asia-Pacific 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-67
5a. CHINA III-68
A.Market Analysis III-68
Outlook III-68
Rising Diabetes Prevalence Bodes Well for Biosensors Market III-68
Government Investments in Environmental Monitoring Boosts
Biosensors Market III-68
Table 77: China's 12th Five Year Plan for Environmental
Protection: Emission Reduction Targets for the Period
2011-2015 (includes corresponding Graph/Chart) III-69
Strategic Corporate Development III-69
B.Market Analytics III-70
Table 78: Chinese Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-70
Table 79: Chinese Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-71
Table 80: Chinese 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-72
5b. REST OF ASIA-PACIFIC III-73
A.Market Analysis III-73
Outlook III-73
India III-73
Diabetic Epidemic Spurs Demand for Biosensors for Blood
Glucose Monitoring in India III-73
Focus on Biosensors' Development III-73
B.Market Analytics III-74
Table 81: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-74
Table 82: Rest of Asia-Pacific Historic Review for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-75
Table 83: Rest of Asia-Pacific 15-Year Perspective for
Biosensors by Product Group/Segment - Percentage Breakdown
of Value Sales for Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) III-76
6. REST OF WORLD III-77
A.Market Analysis III-77
Outlook III-77
Rising Diabetes Population: An Opportunity Indicator III-77
Table 84: Central and South American Population and
Diabetes Prevalence Statistics (2013E) - Select Regions
with High Prevalence of Diabetes for Various Age Groups and
Gender (includes corresponding Graph/Chart) III-77
Table 85: African Population and Diabetes Prevalence
Statistics (2013) - Select Regions with High Prevalence of
Diabetes for Various Age Groups and Gender (includes
corresponding Graph/Chart) III-78
Table 86: Middle East and North African Population and
Diabetes Prevalence Statistics (2013E) - Select Regions
with High Prevalence of Diabetes for Various Age Groups and
Gender (includes corresponding Graph/Chart) III-79
B.Market Analytics III-80
Table 87: Rest of World Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-80
Table 88: Rest of World Historic Review for Biosensors by
Product Group/Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-81
Table 89: Rest of World 15-Year Perspective for Biosensors
by Product Group/Segment - Percentage Breakdown of Value
Sales for Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-82
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 83 (including Divisions/Subsidiaries - 97)
The United States (62)
Canada (2)
Japan (5)
Europe (22)
- France (1)
- Germany (3)
- The United Kingdom (7)
- Italy (1)
- Rest of Europe (10)
Asia-Pacific (Excluding Japan) (6)
Download the full report: https://www.reportbuyer.com/product/2568579/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article